SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000893220-06-001538
Filing Date
2006-07-06
Accepted
2006-07-06 16:56:47
Documents
3
Period of Report
2006-06-29
Items
Item 2.02: Results of Operations and Financial Condition
Item 4.02: Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K PAR PHARMACEUTICAL COMPANIES,INC. w22967e8vk.htm 8-K 18043
2 PRESS RELEASE w22967exv99w1.htm EX-99.1 10387
3 GRAPHIC w22967w2296700.gif GRAPHIC 1894
  Complete submission text file 0000893220-06-001538.txt   32991
Mailing Address 300 TICE BOULEVARD WOODCLIFF LAKE NJ 07677
Business Address 300 TICE BOULEVARD WOODCLIFF LAKE NJ 07677 845-425-7100
PAR PHARMACEUTICAL COMPANIES, INC. (Filer) CIK: 0000878088 (see all company filings)

IRS No.: 223122182 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-10827 | Film No.: 06948599
SIC: 2834 Pharmaceutical Preparations